Tatva Chintan Pharma Chem Limited — Others, 26-08-2025: Shareholders meeting

Tatva Chintan Pharma Chem will convene its 29th Annual General Meeting on 26 September 2025 through video conference. Shareholders will consider adopting the FY25 audited financial results, reporting revenue from operations of 366.42 Cr and profit of 0.33 Cr. A dividend of ₹1 per equity share is proposed. Key proposals include re-appointing Mr. Chintan Nitinkumar Shah as Managing Director and two Whole-time Directors for one year, each with an annual remuneration of about 1.65 Cr. Additionally, three Independent Directors are up for re-appointment for a second five-year term, ensuring leadership continuity and robust governance.